...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Do Health Professionals have Positive Perception Towards Consumer Reporting of Adverse Drug Reactions?
【24h】

Do Health Professionals have Positive Perception Towards Consumer Reporting of Adverse Drug Reactions?

机译：卫生专业人员是否对消费者的药物不良反应报告有正面看法？

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aim: The aim of this study was to evaluate the perceptions of general practitioners (GPs) and community pharmacists (CPs) in Penang, Malaysia, towards consumer reporting of Adverse Drug Reactions (ADRs).Methodology: A cross-sectional mail survey was adopted for the performance of the study. Survey questionnaires were sent to 192 CPs and 400 GPs in the state of Penang, Malaysia. Reminders were sent to all the non-respondents after 3 weeks of the initial mailing. Data which were collected from the questionnaires were analyzed by using the Statistical Package for Social Science (SPSS), version 15. The Chi-square test was used to determine as to whether there was any significant difference between expected and observed frequencies at the alpha level of 0.05.Results: Only 104 respondents (47 CPs and 57 GPs) returned the survey, with a response rate of 18.0%- a figure which could be considered to be low. This study indicated that GPs and CPs were aware about the importance and benefits of consumer reporting. A majority of them (88.0%) thought that consumer reporting would add more benefits to the existing pharmacovigilance program. Similarly, 97% of the respondents agreed that reporting of ADRs was necessary and 87.0% respondents had seen ADRs among their patients. However, 57 of them (6.0%), had not been aware that the national program in Malaysia allowed consumers to report ADRs. A majority of them (97.0%) agreed that consumers needed more education regarding ADR reporting. Most of them (84.0%) thought that consumers could not write valid reports which were similar to reports which were made by healthcare professionals (HCPs). A majority of the respondents (68.0%) had not heard about the consumer reporting program in Malaysia and half of them did not believe that consumer reporting could overcome under-reporting, which was the main problem of the national pharmacovigilance program in Malaysia.Conclusion: The GPs and CPs were aware about the importance and benefits of consumer reporting. Such reporting will add more benefits to the existing programmes in Malaysia, although the barrier that we are facing now is the doubt that they hold over patients? ability to write valid reports which are similar to reports which are made by healthcare professionals (HCPs). Therefore, the consumers need to be educated more about their medications, on how to validate any complaints that they had about the drug consumption and on how to file a proper report and channel it to the ?right? person or bodies. Equally importantly, the media and the non-governmental organizations (NGOs) should play an important role in determining the success of consumer reporting.
机译：目的：本研究旨在评估马来西亚槟城的全科医生（GPs）和社区药剂师（CPs）对不良反应（ADR）的消费者报告的方法。为了研究的表现。调查问卷已发送给马来西亚槟城州的192个CP和400个GP。初始邮件寄出3周后，便向所有未答复者发送了提醒。使用社会科学统计软件包（SPSS）第15版对从调查表中收集的数据进行了分析。卡方检验用于确定alpha级别上的预期频率与观察到的频率之间是否存在显着差异。的0.05。结果：只有104位受访者（47位CP和57位GP）返回了调查，反馈率为18.0％，这个数字可以认为是低的。这项研究表明，GP和CP都意识到消费者报告的重要性和好处。他们中的大多数人（88.0％）认为，消费者报告将为现有的药物警戒计划带来更多好处。同样，有97％的受访者同意必须报告ADR，而87.0％的受访者在其患者中见过ADR。但是，其中有57位（6.0％）尚未意识到马来西亚的国家计划允许消费者报告ADR。他们中的大多数（97.0％）同意，消费者需要接受更多有关ADR报告的教育。他们中的大多数人（84.0％）认为消费者无法编写与医疗保健专业人员（HCP）所做的报告类似的有效报告。大多数受访者（68.0％）尚未听说马来西亚的消费者报告计划，其中一半不相信消费者报告可以克服报告不足的问题，这是马来西亚国家药物警戒计划的主要问题。 GP和CP意识到消费者报告的重要性和好处。这样的报告将为马来西亚现有的计划带来更多的好处，尽管我们现在面临的障碍是怀疑它们是否会影响患者？能够编写类似于医疗保健专业人员（HCP）所做报告的有效报告。因此，需要对消费者进行更多的药物治疗教育，如何验证他们对药物消费的投诉，如何提交适当的报告并将其传达给正确的人？人或身体。同样重要的是，媒体和非政府组织（NGO）应在决定消费者报道的成功方面发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号